Financial & Business News

Microsoft said Saturday that clients of its Azure cloud platform might experience increased latency after multiple undersea cables were cut in the Red Sea.

NEW YORK , Sept. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that Designer Brands may have issued materially misleading business information to the investing public.

The market was less than impressed with the top-line results from Viking Therapeutics' (VKTX 1.73%) phase 2 trial of an oral formulation of its anti-obesity drug VK2735. The disappointment created the sense that the stock lacks any near-term catalysts -- phase 3 results from VK2735 in subcutaneous (injection) form aren't likely until 2027 -- and that the excitement around the stock was primarily centered on the oral formulation.

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in  RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmore directly at (212) 355-4648.

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In XPLR Infrastructure (XIFR) To Contact Him Directly To Discuss Their Options If you purchased or acquired common units in  XPLR Infrastructure between September 27, 2023 and January 27, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK, Sept.

Bristol-Myers Squibb is a Strong Buy at current levels, with a $54 price target and attractive 5.2% dividend yield. The company's innovative growth portfolio is gaining traction, offsetting legacy declines and positioning BMY for a turnaround. Valuation is compelling: BMY trades at a deep discount to peers, with limited downside and strong profitability metrics.

Eight OPEC+ members say they will boost production by 137,000 barrels a day in October, beginning to roll back some voluntary cuts previously put in place.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

U.S. equity markets pushed higher this past week - while short-term benchmark interest rates plunged to three-year lows - after employment data provided decisive evidence of cooling labor markets. Viewed by markets as a "Goldilocks" set of reports, the reports showed slowing - but still positive - job growth in August alongside consistent evidence of cooling wage pressures and emerging slack. A notable milestone after several years of ultra-tight labor markets, the number of job seekers surpassed the number of available job openings for the first time since April 2021.

I bought $10,000 of BRK.B on recent weakness, seeing Berkshire as a defensive anchor amid market volatility and a prudent long-term holding. Valuation remains elevated, with shares rarely trading at a discount and buybacks paused, but relative to an overpriced market, BRK offers a decent opportunity. Transition to Greg Abel as CEO in 2026 should bring a more hands-on, internal capital deployment focus, especially in energy and possibly international expansion.